Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia.
J L Nichol, … , E Choi, J Bogenberger
J L Nichol, … , E Choi, J Bogenberger
Published June 1, 1995
Citation Information: J Clin Invest. 1995;95(6):2973-2978. https://doi.org/10.1172/JCI118005.
View: Text | PDF
Research Article Article has an altmetric score of 3

Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia.

  • Text
  • PDF
Abstract

The present study shows that recombinant human megakaryocyte growth and development factor (r-HuMGDF) behaves both as a megakaryocyte colony stimulating factor and as a differentiation factor in human progenitor cell cultures. Megakaryocyte colony formation induced with r-HuMGDF is synergistically affected by stem cell factor but not by interleukin 3. Megakaryocytes stimulated with r-HuMGDF demonstrate progressive cytoplasmic and nuclear maturation. Measurable levels of megakaryocyte growth and development factor in serum from patients undergoing myeloablative therapy and transplantation are shown to be elaborated in response to thrombocytopenic stress. These data support the concept that megakaryocyte growth and development factor is a physiologically regulated cytokine that is capable of supporting several aspects of megakaryopoiesis.

Authors

J L Nichol, M M Hokom, A Hornkohl, W P Sheridan, H Ohashi, T Kato, Y S Li, T D Bartley, E Choi, J Bogenberger

×

Total citations by year

Year: 2020 2018 2015 2014 2013 2010 2009 2008 2007 2006 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 Total
Citations: 1 1 1 2 1 2 1 2 1 1 7 2 4 5 15 17 32 17 14 2 128
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (128)

Title and authors Publication Year
Development and characterization of a novel, megakaryocyte NF‐κB reporter cell line for investigating inflammatory responses
TM Vallance, JJ Sheard, Y Meng, EC Torre, K Patel, D Widera, S Vaiyapuri
Journal of Thrombosis and Haemostasis 2020
GPIbα is required for platelet-mediated hepatic thrombopoietin generation
M Xu, J Li, MA Neves, G Zhu, N Carrim, R Yu, S Gupta, J Marshall, O Rotstein, J Peng, M Hou, S Kunishima, J Ware, DR Branch, AH Lazarus, ZM Ruggeri, J Freedman, H Ni
Blood 2018
Thrombopoiesis
K Kaushansky
Seminars in Hematology 2015
Thrombopoietin from beginning to end
IS Hitchcock, K Kaushansky
British Journal of Haematology 2014
Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation
KR Machlus, JN Thon, JE Italiano
British Journal of Haematology 2014
Thrombopoietin levels in patients with disorders of platelet production: Diagnostic potential and utility in predicting response to TPO Receptor agonists
RS Makar, OS Zhukov, MA Sahud, DJ Kuter
American Journal of Hematology 2013
Thrombopoietic agents
R Stasi, J Bosworth, E Rhodes, MS Shannon, F Willis, EC Gordon-Smith
Blood Reviews 2010
A biomathematical model of human thrombopoiesis under chemotherapy
M Scholz, A Gross, M Loeffler
Journal of Theoretical Biology 2010
PEGylated Protein Drugs: Basic Science and Clinical Applications
FM Veronese
2009
Emerging treatments for thrombocytopenia: Increasing platelet production
K Peeters, JM Stassen, D Collen, CV Geet, K Freson
Drug Discovery Today 2008
Biopharmaceutical Drug Design and Development
S Wu-Pong, Y Rojanasakul
2008
Historical review: megakaryopoiesis and thrombopoiesis
K Kaushansky
Blood 2007
AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP
JB Bussel, DJ Kuter, JN George, R McMillan, LM Aledort, GT Conklin, AE Lichtin, RM Lyons, J Nieva, JS Wasser, I Wiznitzer, R Kelly, CF Chen, JL Nichol
New England Journal of Medicine 2006
Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies
LM Aledort, CP Hayward, MG Chen, JL Nichol, J Bussel
American Journal of Hematology 2004
Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients
SG Zakynthinos, S Papanikolaou, T Theodoridis, EG Zakynthinos, V Christopoulou-Kokkinou, G Katsaris, AC Mavrommatis
Critical Care Medicine 2004
Proportion of Megakaryocyte Progenitors in Cord Blood Correlates with Platelet Recovery after Cord Blood Transplant
H IKEDA, K ISOYAMA, H SASAKI, D TOYAMA, S YAMAMOTO, Y ARITA, I HOSAKI, Y HIROTA, K YAMADA, H NISHIHIRA
The Showa University Journal of Medical Sciences 2004
Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma
Shinn-Jang Hwang, Jiing-Chyuan Luo, Chung-Pin Li, Cheng-Wei Chu, Jaw-Ching Wu, Chiung-Ru Lai, Jen-Huei Chiang, Gar-Yang Chau, Wing-Yiu Lui, Chun-Chung Lee, Full-Young Chang, Shou-Dong Lee
World journal of gastroenterology : WJG 2004
Thrombocytosis: A paraneoplastic syndrome in patients with hepatocellular carcinoma
SJ Hwang
World journal of gastroenterology : WJG 2004
Hematopoietic Growth Factors in Oncology
G Morstyn, MA Foote, GJ Lieschke
2004
Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities
K Inagaki, T Oda, Y Naka, H Shinkai, N Komatsu, H Iwamura
Blood 2004
Etiology of the myeloproliferative disorders: the role of thrombopoietin
K Kaushansky
Seminars in Hematology 2003
Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood
LF Schipper, A Brand, N Reniers, CJ Melief, R Willemze, WE Fibbe
Experimental Hematology 2003
Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo
S Scheding, M Bergmann, A Shimosaka, P Wolff, C Driessen, G Rathke, K Jaschonek, W Brugger, L Kanz
Transfusion 2002
Human megakaryocytes cultured in vitro accumulate serotonin but not meta-iodobenzylguanidine whereas platelets concentrate both
GA Tytgat, MD Brug, PA Voûte, LA Smets, M Rutgers
Experimental Hematology 2002
Pharmacodynamic Modeling of Thrombopoietin, Platelet, and Megakaryocyte Dynamics in Patients with Acute Myeloid Leukemia Undergoing Dose Intensive Chemotherapy
SH Bernstein, WJ Jusko, W Krzyzanski, J Nichol, M Wetzler
The Journal of Clinical Pharmacology 2002
Serum thrombopoietin levels and anti-thrombopoietin antibodies in systemic lupus erythematosus
W Füreder, U Firbas, JL Nichol, J Pistillo, S Winkler, H Hiesberger, WR Sperr, J Smolen, G Schett
Lupus 2002
Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia
M Briggs, JA Adams, ML Brereton, R Burgess, K Hyde, H Lenehan, JA Yin
British Journal of Haematology 2001
Analysis of the kinetics of TPOuptake during platelet transfusion
CC Folman, SM de Jong, M Haas, AE von Borne
Transfusion 2001
Hydroxyurea-associated Platelet Count Oscillations in Polycythemia Vera: A Report of Four New Cases and a Review
DP Steensma, CN Harrison, A Tefferi
Leukemia & Lymphoma 2001
KINETIC ANALYSIS OF MEGAKARYOPOIESIS INDUCED BY RECOMBINANT HUMAN INTERLEUKIN 11 IN MYELOSUPPRESSED MICE
M Saitoh
Cytokine 2001
Kinetics of CFU-Mk after automated plateletpheresis
T Wagner, DW Schwartz, M Winter, E Kabrna, M Kollars, I Schwarzinger, G Lanzer, WR Mayr, K Geissler
Vox Sanguinis 2001
Thrombopoietin Is Synergistic with Other Cytokines for Expansion of Cord Blood Progenitor Cells
JH Won, SD Cho, SK Park, GT Lee, SH Baick, WS Suh, DS Hong, HS Park
Journal of Hematotherapy & Stem Cell Research 2000
Hepatocyte growth factor/scatter factor enhances the thrombopoietin mRNA expression in rat hepatocytes and cirrhotic rat livers
K Yamashita, H Matsuoka, T Ochiai, R Matsushita, Y Kubuki, M Suzuki, H Tsubouchi
Journal of Gastroenterology and Hepatology 2000
Technical Aspects and Clinical Impact of Hematopoietic Progenitor Subset Quantification
J Baech, HE Johnsen
Stem Cells 2000
Thrombopoietin Levels in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
C Yoshimura, S Nomura, K Katsura, K Yamaguchi, S Fukuhara
Vox Sanguinis 2000
CFU-Mk Content of Immunoselected CD34+ Peripheral Blood Progenitor Cells, Evaluated with an Adapted Serum-Free Methylcellulose Assay, Is Predictive of Platelet Lineage Reconstitution in Children with Solid Tumors
N Boiret, J Kanold, M Fouassier, JM Bons, P Halle, C Rapatel, J Berger, P Pireyre, V Blanzat, P Travade, J Bonhomme, F Demeocq, MG Berger
Journal of Hematotherapy & Stem Cell Research 2000
Stressful delivery influences circulating thrombopoietin (TPO) levels in newborns: possible role for cortisol in TPO-mpl binding
K Ikeno, K Koike, A Takeshita, K Shinjo, T Higuchi, T Nakabayashi, S Akanuma, K Hizume, A Ishiguro, K Ogami, T Kato, H Miyazaki, R Ohno, A Komiyama
Early Human Development 2000
Pharmacokinetic Analysis of Pegylated Megakaryocyte Growth and Development Factor in Humans
RH de Boer, LK Roskos, E Cheung, S Fox, RL Basser, J Marty, CG Begley, J Cebon
Growth Factors 2000
Use of PEG-rHuMGDF in platelet engraftment after autologous stem cell transplantation
KK Fields, M Crump, I Bence-Bruckler, S Bernstein, S Williams, S Frankel, A Miller, G Demetri, JM Nabholtz, S Cruickshank, M Lill
Bone Marrow Transplantation 2000
Thrombopoietic cytokines in relation to platelet recovery after bone marrow transplantation
DJ Weisdorf, T DeFor, J Nichol, A Panoskaltsis-Mortari, BR Blazar
Bone Marrow Transplantation 2000
The frequency and proliferative potential of megakaryocytic colony-forming cells (Meg-CFC) in cord blood, cytokine-mobilized peripheral blood and bone marrow and their correlation with total CFC numbers: implications for the quantitation of Meg-CFC to predict platelet engraftment following cord blood transplantation
A Drygalski, G Xu, D Constantinescu, I Kashiwakura, T Farley, L Dobrila, P Rubinstein, JW Adamson
Bone Marrow Transplantation 2000
Flow cytometric detection of growth factor receptors in autografts and analysis of growth factor concentrations in autologous stem cell transplantation: possible significance for platelet recovery
I Schiødt, CH Jensen, E Kjærsgaard, E Gaarsdal, K Nikolajsen, HE Johnsen
Bone Marrow Transplantation 2000
Defective Megakaryocytic Development in Myelodysplastic Syndromes
WK Hofmann, U Kalina, S Koschmieder, G Seipelt, D Hoelzer, OG Ottmann
Leukemia & Lymphoma 2000
THROMBOCYTOPENIA IN LIVER TRANSPLANT RECIPIENTS: Predictors, Impact on Fungal Infections, and Role of Endogenous Thrombopoietin
FY Chang, N Singh, T Gayowski, MM Wagener, SM Mietzner, JE Stout, IR Marino
Transplantation 2000
Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers
LA Harker, LK Roskos, UM Marzec, RA Carter, JK Cherry, B Sundell, EN Cheung, D Terry, W Sheridan
Blood 2000
Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia
AA Axelrad, D Eskinazi, PN Correa, D Amato
Blood 2000
Physiology and clinical applications of platelet growth factors
LA Harker
Current Opinion in Hematology 1999
Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment
K Kinjo, M Kizaki, N Takayama, N Michikawa, A Oda, SI Okamoto, T Tahara, T Kato, H Miyazaki, Y Ikeda
British Journal of Haematology 1999
Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation
J Goulis, TN Chau, S Jordan, AB Mehta, A Watkinson, K Rolles, AK Burroughs
Gut 1999
A Case of Thrombopoietin-Producing Ovarian Carcinoma Confirmed by Immunohistochemistry
M Furuhashi, Y Miyabe, H Oda
Gynecologic Oncology 1999
Relationship between megakaryocyte mass and serum thrombopoietin levels as revealed by a case of cyclic amegakaryocytic thrombocytopenic purpura
CS Zent, J Ratajczak, MZ Ratajczak, J Anastasi, PC Hoffman, AM Gewirtz
British Journal of Haematology 1999
The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEGrHuMGDF) on megakaryopoiesis in patients with aplastic anaemia
ML Brereton, JA Adams, M Briggs, JA Yin
British Journal of Haematology 1999
Endogenous thrombopoietin serum levels during multicycle chemotherapy
C Engel, M Loeffler, H Franke, S Schmitz
British Journal of Haematology 1999
Age-related changes in thrombopoietin in children: reference interval for serum thrombopoietin levels
A Ishiguro, T Nakahata, K Matsubara, Y Hayashi, T Kato, Y Suzuki, T Shimbo
British Journal of Haematology 1999
Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics
J Li, Y Xia, DJ Kuter
British Journal of Haematology 1999
A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocytic progenitors and megakaryocytes for transfusion purposes
S Oudenrijn, M Haas, J Calafat, CE van der Schoot, AE von Borne
British Journal of Haematology 1999
Thrombopoietin and the c-Mpl receptor: insights from gene targeting
WS Alexander
The International Journal of Biochemistry & Cell Biology 1999
Elevated Serum Thrombopoietin and Interleukin-6 Concentrations in Thrombocytosis Associated with Inflammatory Bowel Disease
F Heits, M Stahl, D Ludwig, EF Stange, W Jelkmann
Journal of Interferon & Cytokine Research 1999
Immature megakaryocytes undergo apoptosis in the absence of thrombopoietin
M Osada, T Komeno, K Todokoro, M Takizawa, H Kojima, K Suzukawa, H Ninomiya, T Abe, T Nagasawa
Experimental Hematology 1999
A Role for Changes in Platelet Production in the Cause of Acute Coronary Syndromes
B van der Loo, JF Martin
Arteriosclerosis, thrombosis, and vascular biology 1999
Advances in Allogeneic Hematopoietic Stem Cell Transplantation
RK Burt, MM Brush
1999
Ex Vivo Cultured Megakaryocytes Express Functional Glycoprotein IIb-IIIa Receptors and Are Capable of Adenovirus-Mediated Transgene Expression
N Faraday, JJ Rade, DC Johns, G Khetawat, SJ Noga, JF DiPersio, Y Jin, JL Nichol, JS Haug, PF Bray
Blood 1999
A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia
E Archimbaud, OG Ottmann, JA Yin, K Lechner, H Dombret, MA Sanz, G Heil, P Fenaux, W Brugger, A Barge, C OBrien-Ewen, J Matcham, D Hoelzer
Blood 1999
Thrombopoietin Level in Young Patients Is Related to Megakaryocyte Frequency and Platelet Count
MU Kuefer, WC Wang, DR Head, JA Wilimas, WL Furman, Q Liu, AC Hornkohl, DM Best, CW Jackson
Journal of Pediatric Hematology/Oncology 1998
Effects of mpl ligands on platelet production and function in nonhuman primates
LA Harker, UM Marzec, AB Kelly
Stem Cells 1998
Cytokines in Hematopoiesis
WS Alexander
International Reviews of Immunology 1998
The Molecular Control of Hematopoiesis: Progress and Problems with Gene Manipulation
D Metcalf
Stem Cells 1998
The combined administration of daniplestim and mpl ligand augments the hematopoietic reconstitution observed with single cytokine administration in a nonhuman primate model of myelosuppression
AM Farese, TJ Macvittie, LB Lind, WG Smith, JP Mckearn
Stem Cells 1998
Unilineage hematopoietic differentiation in bulk and single cell culture
B Ziegler, U Testa, L Vitelli, M Valtieri, C Peschle, G Condorelli
Stem Cells 1998
The Mpl ligand and platelet homeostasis
JL Nichol
Acta Paediatrica 1998
Overview of the safety and biologic effects of peg‐rhumgdf in clinical trials
W Sheridan, D Menchaca
Stem Cells 1998
Thrombopoietin level is inversely related to blast count, not platelet number, in Down syndrome neonates with transient myeloproliferative disorder
M Bonno, E Azuma, H Kawasaki, XL Zhang, Y Komada, M Hirayama, M Higashigawa, M Umemoto, T Koike, T Kato, T Tahara, H Miyazaki, M Sakurai
American Journal of Hematology 1998
Interferon-γ and Human Megakaryopoiesis
K Tsuji, K Muraoka, T Nakahata
Leukemia & Lymphoma 1998
Neutralization of Biological Activity and Inhibition of Receptor Binding by Antibodies Against Human Thrombopoietin
T Tahara, T Kuwaki, A Matsumoto, H Morita, H Watarai, Y Inagaki, H Ohashi, K Ogami, H Miyazaki, T Kato
Stem Cells 1998
Early australian clinical studies with pegylated recombinant human megakaryocyte growth and development factor
RL Basser
Stem Cells 1998
Endogenous TPO (eTPO) levels in health and disease: Possible clues for therapeutic intervention
JL Nichol
Stem Cells 1998
Thrombopoietic factors potentially useful in the treatment of acute leukemia
E Archimbaud, X Thomas
Leukemia Research 1998
Therapeutic Cytokine Stimulation of Thrombocytopoiesis
LA Harker
Transfusion Science 1998
10 Thrombopoietin and its receptor: structure, function and role in the regulation of platelet production
AE von Borne, C Folman, GE Linthorst, L Porcelijn, S Oudenrijn, E der Schoot, M Haas
Baillière's Clinical Haematology 1998
11 Thrombopoietin: its role in platelet disorders and as a new drug in clinical medicine
AE von Borne, C Folman, GE Linthorst, L Porcelijn, S Oudenrijn, E der Schoot, M Haas
Baillière's Clinical Haematology 1998
Quantitative analysis of thrombopoietin receptors on human megakaryocytes
T Kuwaki, T Hagiwara, C Yuki, I Kodama, T Kato, H Miyazaki
FEBS Letters 1998
Expression and Function of the Megakaryocyte Growth and Development Factor Receptor in Acute Myeloid Leukemia Blasts
M Wetzler, SH Bernstein, H Baumann, KM Fries, C Stewart, L Blumenson, MR Baera, GP Herziga, CD Bloomfielda, JL Slack
Leukemia & Lymphoma 1998
Thrombocytopenia—Platelet Support or Growth Factors?
R Manley, MF Murphy
Hematology 1998
Interferon-induced thrombocytopenia: Is it time for thrombopoietin?
TG Martin, MA Shuman
Hepatology 1998
The Effect of Hematopoietic Growth Factors on Platelet Aggregability
A Kaplan, S Kaplan, KF Marcoe, LR Sauvage, WP Hammond
Clinical and Applied Thrombosis/Hemostasis 1998
Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34+ cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF)
L Catani, L Gugliotta, E Campanini, S Mangianti, D Gibellini, S Baravelli, N Vianelli, RM Lemoli, S Tura
British Journal of Haematology 1998
Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C
M Peck-Radosavljevic, M Wichlas, J Pidlich, P Sims, G Meng, J Zacherl, S Garg, C Datz, A Gangl, P Ferenci
Hepatology 1998
Acute Leukemias VII
W Hiddemann, T Büchner, B Wörmann, J Ritter, U Creutzig, M Keating, W Plunkett
1998
Cyclical Neutropenia and Other Periodic Hematological Disorders: A Review of Mechanisms and Mathematical Models
C Haurie, DC Dale, MC Mackey
Blood 1998
Ineffective Platelet Production in Thrombocytopenic Human Immunodeficiency Virus–Infected Patients
JL Cole, UM Marzec, CJ Gunthel, S Karpatkin, L Worford, IB Sundell, JL Lennox, JL Nichol, LA Harker
Blood 1998
Treatment of Thrombocytopenia in Chimpanzees Infected With Human Immunodeficiency Virus by Pegylated Recombinant Human Megakaryocyte Growth and Development Factor
LA Harker, UM Marzec, F Novembre, IB Sundell, EK Waller, S Karpatkin, HM McClure, AB Kelly, RB Stead
Blood 1998
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
SD Lyman, SE Jacobsen
Blood 1998
Multilineage Hematopoietic Recovery by a Single Injection of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor in Myelosuppressed Mice
K Shibuya, H Akahori, K Takahashi, E Tahara, T Kato, H Miyazaki
Blood 1998
Effects of Cytokines on Platelet Production From Blood and Marrow CD34+ Cells
F Norol, N Vitrat, E Cramer, J Guichard, SA Burstein, W Vainchenker, N Debili
Blood 1998
Interactions of Erythropoietin, Granulocyte Colony-Stimulating Factor, Stem Cell Factor, and Interleukin-11 on Murine Hematopoiesis During Simultaneous Administration
I Roeder, G de Haan, C Engel, W Nijhof, B Dontje, M Loeffler
Blood 1998
Regulation of polymorphonuclear cell activation by thrombopoietin
MF Brizzi, E Battaglia, A Rosso, P Strippoli, G Montrucchio, G Camussi, L Pegoraro
Journal of Clinical Investigation 1997
Effect of Recombinant Interleukin-6 and Thrombopoietin on Isolated Guinea Pig Bone Marrow Megakaryocyte Protein Phosphorylation and Proplatelet Formation
RM Leven, B Clark, F Tablin
Blood Cells, Molecules, and Diseases 1997
The impact of thrombopoietin and related Mpl-Ligands on transfusion medicine
AM Farese, CA Schiffer, TJ MacVittie
Transfusion Medicine Reviews 1997
THROMBOPOIETIN: UNDERSTANDING AND MANIPULATING PLATELET PRODUCTION
KK MD
Annual Review of Medicine 1997
Thrombopoietin
K Kaushansky
Trends in Endocrinology & Metabolism 1997
1 The evolution of megakaryocytes to platelets
P Nurden, C Poujol, AT Nurden
Baillière's Clinical Haematology 1997
Serum thrombopoietin and interleukin 6 concentrations in tumour patients and response to chemotherapy-induced thrombocytopenia
F Heits, DM Katschinski, U Wilmsen, GJ Wiedemann, W Jelkmann
European Journal of Haematology 1997
Effects of Polyethylene Glycol–Conjugated Recombinant Human Megakaryocyte Growth and Development Factor on Platelet Counts after Chemotherapy for Lung Cancer
M Fanucchi, J Glaspy, J Crawford, J Garst, R Figlin, W Sheridan, D Menchaca, D Tomita, H Ozer, L Harker
New England Journal of Medicine 1997
Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver?
M Peck-Radosavljevic, J Zacherl, YG Meng, J Pidlich, E Lipinski, F Längle, R Steininger, F Mühlbacher, A Gangl
Journal of Hepatology 1997
Cytokines, platelet production and hemostasis
SA Burstein
Platelets 1997
Thrombopoiesis and Thrombopoietins
DJ Kuter, P Hunt, W Sheridan, D Zucker-Franklin
1997
Prevention of Thrombocytopenia and Neutropenia in a Nonhuman Primate Model of Marrow Suppressive Chemotherapy by Combining Pegylated Recombinant Human Megakaryocyte Growth and Development Factor and Recombinant Human Granulocyte Colony-Stimulating Factor
LA Harker, UM Marzec, AB Kelly, E Cheung, A Tomer, JL Nichol, SR Hanson, RB Stead
Blood 1997
A Single Injection of Pegylated Murine Megakaryocyte Growth and Development Factor (MGDF ) Into Mice Is Sufficient to Produce a Profound Stimulation of Megakaryocyte Frequency, Size, and Ploidization
JT Arnold, NC Daw, PE Stenberg, D Jayawardene, DK Srivastava, CW Jackson
Blood 1997
Human Platelets as a Model for the Binding and Degradation of Thrombopoietin
PJ Fielder, P Hass, M Nagel, E Stefanich, R Widmer, GL Bennett, GA Keller, FJ de Sauvage, D Eaton
Blood 1997
Human Platelets Display High-Affinity Receptors for Thrombopoietin
VC Broudy, NL Lin, DF Sabath, T Papayannopoulou, K Kaushansky
Blood 1997
Thrombopoietin in Patients With Congenital Thrombocytopenia and Absent Radii: Elevated Serum Levels, Normal Receptor Expression, But Defective Reactivity to Thrombopoietin
M Ballmaier, H Schulze, G Strauβ, K Cherkaoui, N Wittner, S Lynen, S Wolters, J Bogenberger, K Welte
Blood 1997
Megakaryocyte Growth and Development Factor: A Review of Early Clinical Studies
R Abraham, RL Basser
The oncologist 1997
Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia
AM Farese, P Hunt, LB Grab, TJ MacVittie
Journal of Clinical Investigation 1996
Thrombopoietin and platelet development
K Kaushansky
The Western journal of medicine 1996
Dissecting Megakaryocytopoiesis in Vivo with Toxigenes
G Marguerie, V Roullot, DT Roux
Stem Cells 1996
Protein Characteristics of Thrombopoietin
T Kato
Stem Cells 1996
The Role of Platelet Growth Factors in Cancer Therapy
K Clarke, RL Basser
Stem Cells 1996
Cytokines at the research-clinical interface: potential applications
TL Holyoake
Blood Reviews 1996
In Vivo Biological Effects of Various Forms of Thrombopoietin in a Murine Model of Transient Pancytopenia
GR Thomas, H Thibodeaux, CJ Errett, J Mathias, M Marian, G Meng, RL Vandlen, DL Eaton
Stem Cells 1996
Preclinical Biology of Megakaryocyte Growth and Development Factor: A Summary
JL Nichol
Stem Cells 1996
Physiologic Role of TPO in Thrombopoiesis
H Miyazaki
Stem Cells 1996
Mechanism of Thrombocytosis in Hepatoblastoma: A Case Report
H Yamaguchi, E Ishii, Y Hayashida, Y Hirata, R Sakai, S Miyazaki
Pediatric Hematology-Oncology 1996
Effects of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor on Thrombocytopenia Induced by a New Myelosuppressive Chemotherapy Regimen in Mice
H Akahori, K Shibuya, M Ozai, M Ida, K Kabaya, T Kato, H Miyazaki
Stem Cells 1996
In Vivo Effects of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor on Hematopoiesis in Normal Mice
K Kabaya, H Akahori, K Shibuya, Y Nitta, M Ida, M Kusaka, T Kato, H Miyazaki
Stem Cells 1996
Megakaryocytes
K Kaushansky
Trends in Cardiovascular Medicine 1996
Thrombopoietin: Biology and Clinical Applications
DJ Kuter
The oncologist 1996
The physiologic role and therapeutic potential of the Mpl‐ligand in thrombopoiesis
P Hunt
Stem Cells 1995
The new generation of recombinant human hematopoietic cytokines
P Hunt, MA Foote
Current Opinion in Biotechnology 1995

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
15 readers on Mendeley
See more details